The time to offer treatments for COVID-19
Background: COVID-19 has several overlapping phases. Treatments to date have focused
on the late stage of disease in hospital. Yet, the pandemic is by propagated by the viral …
on the late stage of disease in hospital. Yet, the pandemic is by propagated by the viral …
Current effective therapeutics in management of COVID-19
K Atluri, I Aimlin, S Arora - Journal of Clinical Medicine, 2022 - mdpi.com
The current pandemic due to the SARS-CoV-2 virus has caused irreparable damage
globally. High importance is placed on defining current therapeutics for Coronavirus …
globally. High importance is placed on defining current therapeutics for Coronavirus …
[PDF][PDF] COVID-19 Treatment: The Race Against Time. Electron J Gen Med. 2020; 17 (6): em227
The new outbreak of the novel coronavirus infection emerged in Wuhan-China in late 2019,
by the end of Mar 2020, it has spread in more than 178 countries and territories. There is no …
by the end of Mar 2020, it has spread in more than 178 countries and territories. There is no …
Possible therapeutic agents for COVID-19: a comprehensive review
KM Elhusseiny, FAE Abd-Elhay… - Expert Review of Anti …, 2020 - Taylor & Francis
Introduction Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has emerged
in China. There are no available vaccines or antiviral drugs for COVID-19 patients. Herein …
in China. There are no available vaccines or antiviral drugs for COVID-19 patients. Herein …
[PDF][PDF] Therapeutics and COVID-19: living guideline, 13 January 2023
World Health Organization - 2023 - apps.who.int
As of December 2022, there have been over 642 million confirmed cases of COVID-19 (10).
The pandemic has thus far claimed approximately 6.62 million lives (10). Vaccination is …
The pandemic has thus far claimed approximately 6.62 million lives (10). Vaccination is …
COVID-19 treatments approved in the European Union and clinical recommendations for the management of non-hospitalized and hospitalized patients
S Bellino - Annals of medicine, 2022 - Taylor & Francis
Background The COVID-19 pandemic caused by SARS-CoV-2 continues to have a serious
impact on public health worldwide. Most patients develop mild to moderate symptoms and …
impact on public health worldwide. Most patients develop mild to moderate symptoms and …
[HTML][HTML] Effective drugs used to combat SARS-CoV-2 infection and the current status of vaccines
A Awadasseid, Y Wu, Y Tanaka, W Zhang - Biomedicine & …, 2021 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a causal factor of the
coronavirus disease 2019 (COVID-19). Drug repurposing, portraying patented drugs as a …
coronavirus disease 2019 (COVID-19). Drug repurposing, portraying patented drugs as a …
Accelerating COVID-19 therapeutic interventions and vaccines (ACTIV): an unprecedented partnership for unprecedented times
FS Collins, P Stoffels - Jama, 2020 - jamanetwork.com
It has been more than a century since the world has encountered a pandemic like
coronavirus disease 2019 (COVID-19), and the rate of spread of COVID-19 around the …
coronavirus disease 2019 (COVID-19), and the rate of spread of COVID-19 around the …
[PDF][PDF] Treatment modalities of the covid-19 pandemic through repurposed drugs and status of vaccines
MS Hussain, PP Mohit… - International Journal of …, 2021 - pdfs.semanticscholar.org
Respiratory diseases are the leading source of morbidity and death for millions around the
world of all ages. A 2019 coronavirus outbreak has occurred in China and is spread quickly …
world of all ages. A 2019 coronavirus outbreak has occurred in China and is spread quickly …
[HTML][HTML] COVID-19 therapy and vaccination: a clinical narrative review
The SARS-CoV-2 pandemic is the most globally impacting health issue our world has faced
over the last century. As of January 7, 2022, around 300 million cases have been reported …
over the last century. As of January 7, 2022, around 300 million cases have been reported …